VOLUME 4 ISSUE 6: Brian Klepper, Principal, Worksite Health Advisors, Discusses High Performing Health Organizations

Dear Colleagues, In this issue, I had the chance to speak with Brian Klepper, Principal, Worksite Health Advisors, a company finding and vetting health care companies that consistently deliver measurably better health outcomes at far lower costs than conventional approaches. In this interview, Klepper explains the benefits of using high-performing organizations,

Industry News: VOLUME 4 ISSUE 6

INDUSTRY NEWS  9 ways Covid-19 may forever upend the U.S. health care industry By Lev Facher statnews.com - In the U.S. alone, Covid-19 has claimed nearly 100,000 lives and 30 million jobs. Beyond grinding day-to-day life to a halt, the pandemic has prompted a reckoning throughout the country’s health care infrastructure, shattering decades-old assumptions

Volume 10, Issue 22: Mike Baldzicki, Executive Vice President, Growth & Strategy, AscellaHealth, Discusses Cost Savings Initiatives for Specialty Pharmacy Benefit Managers and Upcoming Webinar Series

Dear Colleagues, Medical Travel Today is excited to bring you an interview with Mike Baldzicki, Executive Vice President, Growth & Strategy at AscellaHealth, a national specialty pharmacy benefit manager serving commercial, Medicare and Medicaid segments, offering high quality prescription drug benefit management services. In this interview, Baldzicki discusses how employers and TPAs are

Spotlight Interview: Michael J. Baldzicki, CRCM Executive Vice President, Growth & Strategy, AscellaHealth

About Michael J Baldzicki, CRCM Executive Vice President, Growth & Strategy, AscellaHealth As an Executive of Growth & Strategy for AscellaHealth, Mike leads Market Access, Business Development & Corporate Strategy for Specialty / Infusion Pharmacy Segments, he provides business strategies of all portfolio management.  Within his roles, he ensures the success of

Industry News: Volume 10, Issue 22

INDUSTRY NEWS Johnson & Johnson to End Talc-Based Baby Powder Sales in North America By Tiffany Hsu and Roni Caryn Rabin nytimes.com - Johnson & Johnson is discontinuing North American sales of its talc-based baby powder, a product that once defined the company’s wholesome image and that it has defended for decades even as it faced

VOLUME 4 ISSUE 5: Sally Rodriguez, Chief of Staff and Director of Products, Health Care Cost Institute, Discusses Healthcare Costs Data and the Effects of COVID-19

Dear Colleagues, In this issue, I had the chance to speak with Sally Rodriguez, Chief of Staff and Director of Products, Health Care Cost Institute (HCCI) an independent, non-profit research institute. In this interview, Rodriguez details how employers can leverage data to keep costs down and how coronavirus has caused people

Spotlight Interview: Sally Rodriguez, Chief of Staff and Director of Products, Health Care Cost Institute

About Sally Rodriguez Ms. Rodriguez oversees HCCI’s research and product portfolios to create impactful offerings in support of its mission. Prior to joining HCCI, Ms. Rodriguez served in a variety of healthcare research, consulting and product development roles, most recently leading product development for Avalere Health and previously conducting research with

Industry News: Volume 4 Issue 5

INDUSTRY NEWS  The Black American Amputation Epidemic by Lizzie Presser propublica.org -It was a Friday evening in the hospital after a particularly grueling week when Dr. Foluso Fakorede, the only cardiologist in Bolivar County, Mississippi, walked into Room 336. Henry Dotstry lay on a cot, his gray curls puffed on a pillow. Fakorede

Volume 10, Issue 21: Simon Estcourt, Managing Director, Aposave, Discusses Providing Medications to Patients Without Commercial Access

Dear Colleagues, Medical Travel Today is excited to bring you an interview with Simon Estcourt, Managing Director, Aposave, a part of the Abacus Medicine Group, a Danish company that focuses on providing access to commercially available products throughout Europe that typically works with wholesalers. In this interview, Estcourt discusses the impact